University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Virology Papers

Virology, Nebraska Center for

March 2006

Conserved Amino Acids of the Human Immunodeficiency Virus
Type 2 Vpx Nuclear Localization Signal Are Critical for Nuclear
Targeting of the Viral Preintegration Complex in Non-Dividing
Cells
Michael Belshan
Creighton University, michaelbelshan@creighton.edu

Lisa A. Mahnke
Washington University School of Medicine

Lee Ratner
Washington University School of Medicine

Follow this and additional works at: https://digitalcommons.unl.edu/virologypub
Part of the Virology Commons

Belshan, Michael; Mahnke, Lisa A.; and Ratner, Lee, "Conserved Amino Acids of the Human
Immunodeficiency Virus Type 2 Vpx Nuclear Localization Signal Are Critical for Nuclear Targeting of the
Viral Preintegration Complex in Non-Dividing Cells" (2006). Virology Papers. 84.
https://digitalcommons.unl.edu/virologypub/84

This Article is brought to you for free and open access by the Virology, Nebraska Center for at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Virology Papers by an
authorized administrator of DigitalCommons@University of Nebraska - Lincoln.

Published in Virology 346:1 (March 1, 2006), pp. 118–126; doi 10.1016/j.virol.2005.10.036
Copyright © 2005 Elsevier Inc. Used by permission. http://www.sciencedirect.com/science/journal/00426822
Submitted June 13, 2005; revised July 29, 2005; accepted October 18, 2005; published online December 1, 2005.

Conserved Amino Acids of the Human Immunodeficiency
Virus Type 2 Vpx Nuclear Localization Signal Are Critical
for Nuclear Targeting of the Viral Preintegration Complex
in Non-Dividing Cells
Michael Belshan,* Lisa A. Mahnke,† and Lee Ratner †
* Department of Medical Microbiology and Immunology, Creighton University, Omaha, NE 68178, USA
† Departments of Medicine, Pathology, and Molecular Microbiology, Washington University School of Medicine,
St. Louis, Box 8069, 660 South Euclid, St. Louis, MO 63110, USA

Corresponding author—L. Ratner, fax 314 747-2120, email lratner@im.wustl.edu
Abstract
The HIV-2 viral accessory protein Vpx is related to, but distinct from the Vpr protein of HIV-1. Vpx is packaged into virions and
as a component of the viral preintegration complex (PIC) is required for efficient virus replication in non-dividing cells. We have
previously reported that the minimal transferable region of Vpx that contained karyophilic properties was aa 65 to 72. Analysis of
Vpx sequences from various HIV-2/SIV strains reveals that this region contains highly conserved amino acids, including two basic residues (K68, R70) and three tyrosines (Y66, Y69, Y71). Here, we demonstrate that mutation of the basic or tyrosine residues
abolishes PIC nuclear import in arrested cells as assessed by PCR detection of viral integration. Examination of cell-free virus by
Western blot indicated that all mutant proteins were incorporated into virions, suggesting that the lack of replication in arrested
cells was not due to a loss of Vpx in target cells. Together, these studies map critical residues of the Vpx nuclear localization signal
that are required for efficient infection of non-dividing cells.
Keywords: HIV-2, Vpx, Preintegration complex, Nuclear localization

1993, and Miller et al., 1997). HIV-2 contains both the vpr
and vpx genes, each with discrete functions (Fletcher et al.,
1996). While Vpx is homologous to HIV-1 Vpr, is packaged into virions, and is a component of the HIV-2 PIC, it
lacks a nuclear export signal and any cell-cycle arrest function (Belshan and Ratner, 2003 and Hansen and Bushman,
1997). Therefore, like HIV-1 Vpr, Vpx is necessary for effective nuclear translocation of the PIC, but is dispensable
for integration. Furthermore, SIVsm Vpx has been demonstrated to be required for efficient virus dissemination and
pathogenesis in vivo (Hirsch et al., 1998).
In addition to its composition, the transport of the PIC
remains one of the least well understood aspects of HIV
replication. Work by McDonald et al. suggests that the PIC
associates with and traverses the microtubule network to
microtubule organizing centers near the nuclear envelope
(McDonald et al., 2002). However, it remains unclear what
facilitates PIC transport along the network. Furthermore,
once the PIC reaches the nuclear membrane, the sequence
of events that result in the nuclear import of the viral ds-

Introduction
A hallmark and critical determinant of the pathogenesis of the lentivirus subfamily of retroviruses is the ability
to infect non-dividing cells. After reverse transcription, targeting of the viral DNA to the nucleus of cells is mediated
by a large nucleoprotein preintegration complex (PIC).
This complex, which has been difficult to characterize, is
comprised of both cellular and viral components. Likely,
only a small number of the cellular proteins associated
with the PIC have been identified. Among those identified, only a few, including barrier to auto integration factor
(BAF) and HMG Y(I), have been shown to be functionally
relevant (Chen and Engelman, 1998, Farnet and Bushman,
1997, Harris and Engelman, 2000, Hindmarsh et al., 1999,
Li et al., 2000, and Lin and Engelman, 2003). The viral components include the dsDNA, reverse transcriptase, matrix,
nucleocapsid, integrase, and Vpr (HIV-1) or Vpx (HIV2/SIV) proteins (Bukrinsky et al., 1993, Farnet and Haseltine, 1991, Hansen and Bushman, 1997, Karageorgos et al.,
118
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DNA remains unclear. Numerous viral components of the
HIV-1 PIC contain one or more karyophilic signals including matrix, integrase, vDNA (central polypurine tract), and
Vpr (or Vpx for HIV-2/SIV) (reviewed in Goff, 2001, Sherman and Greene, 2002, and Stevenson, 1996). However, deletion of any single signal results in only a modest reduction of PIC import efficiency. Therefore, these signals do
not appear to be synergistic, but rather redundant.
HIV-2 Vpx is a small hydrophobic protein that is a component of the PIC and required for efficient infection of nondividing cells (Mahalingam et al., 2001, Pancio et al., 2000,
and Ueno et al., 2003). The localization of Vpx is context dependent. Vpx has a nuclear localization signal (NLS), but
no NES (Belshan and Ratner, 2003). In the presence of unprocessed Gag in a virus producing cell, Vpx is packaged
into virions through an interaction with the p6 region of
Gag (Jin et al., 2001, Pancio and Ratner, 1998, and Selig et
al., 1999). Packaging of Vpx is necessary for its activity during the early stage of virus replication. Expressed in the absence of the Gag polyprotein, Vpx predominantly localizes
to the nuclei of cells (Belshan and Ratner, 2003, Mahalingam
et al., 2001, and Pancio et al., 2000). We have mapped a minimal transferable nuclear localization signal (NLS) to amino
acids 65–72 (Belshan and Ratner, 2003); however, other Cterminal residues have been implicated in regulating Vpx
nuclear localization and PIC import in non-dividing cells
(Belshan and Ratner, 2003, Pancio et al., 2000, and Rajendra Kumar et al., 2003). In these studies, there exists a strong
correlation between the ability of Vpx mutants to localize to
the nucleus and the ability of viruses containing those mutations to infect non-dividing cells. Thus, Vpx appears to be
a critical regulator of HIV-2/SIV PIC nuclear import.
The goal of our ongoing studies is to characterize the
pathway of Vpx nuclear import as a means to dissect the
process of PIC transport and nuclear targeting. We have examined the minimal transferable nuclear localization signal
of HIV-2 Vpx (…65SYTKYRYL72…). This stretch of amino
acids is highly conserved among HIV-2/SIV strains (Figure
1A), further suggestive evidence of the importance of this
region. Here, we use mutational analysis to study the Vpx
NLS and characterize the role of Vpx in PIC nuclear transport. We define three critical residues (K68, Y69, R70) in the
minimal transferable NLS required for HIV-2 infection of
non-dividing cells. Mutation of any of these residues did
not appear to inhibit Vpx incorporation into virions, suggesting that the NLS is separable from the packaging domain of Vpx. Nor did these mutations impede HIV-2 infection of dividing cells. Thus, we have defined several critical
cis-acting residues of the Vpx NLS for targeting of the HIV2 PIC in non-dividing cells.

clear import and the role of Vpx in preintegration complex
(PIC) nuclear targeting. Examination of various HIV-2 and
SIV Vpx sequences in the Los Alamos Database indicated
that several amino acids within this region are highly conserved among the HIV-2/SIV family (Figure 1A), suggesting they are essential for the function of the protein. In our
previous study, we noted that alanine substitution of both
basic residues (K68 and R70) and/or the three tyrosine residues (Y66, Y69, Y71), but not the serine residues ablated the
nuclear localization of a green fluorescent protein-Vpx fusion protein (Belshan and Ratner, 2003). In the present studies, we wished to determine the effect of these substitutions
in Vpx on PIC import. Therefore, we constructed a series of
full length HIV-2 ROD10 molecular clones containing these
original alanine substitutions in Vpx and also constructed
additional Vpx mutants with different combinations of alanine substitutions for the tyrosine residues (Figure 1B).

Results

Figure 1. Conservation of the Vpx NLS and mutants constructed for these studies. (A) Alignment of selected sequences
from the Los Alamos HIV sequence database. The consensus
sequence is given at the top. Capital letters indicate highly
conserved amino acid residues, small-case letters denote dominant amino acid residues, ‘x’ indicates no dominant residue.
(B) Summary of the mutations constructed for the studies presented. RMX-Δ represents a clone in which both methionine
codons of vpx have been altered to abolish protein translation.

Mutagenesis of conserved amino acids in the Vpx nuclear localization signal (NLS)
Our previous studies identified two transferable NLSs
of Vpx that overlapped at amino acids 65–72 (Belshan and
Ratner, 2003). Our next goal was to identify the critical residues of Vpx to further characterize the pathway of Vpx nu-

Infection of MAGI-5 cells with viruses containing alanine substitutions in the Vpx NLS
It has been known for some time that Vpx is dispensable for replication in dividing cells in vitro (Hu et al., 1989,
Kappes et al., 1991, Marcon et al., 1991, Shibata et al., 1990,
and Yu et al., 1991). To confirm that the molecular clones we
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constructed were viable, we assayed the ability of each virus to infect MAGI-5 indicator cells. Viruses were produced
by transfection of 293T cells, concentrated, and quantified by p27 ELISA. MAGI-5 cells were infected in 96-well
plates with equal amounts of virus (usually 5 ng/well) for
48 h, then fixed and stained for β-galactosidase expression.
The virus titer was calculated by the number of blue nuclei. As expected, all viruses, including the vpx-deleted virus (RMX-delta) retained the ability to infect dividing cells
(Figure 2). With the exception of the triple tyrosine to alanine mutant (RMX-Y-A), all the viruses infected the cells
at levels similar to the wild-type ROD10. RMX-Y-A consistently displayed approximately 70% of the level of infection of the wild-type ROD10.
Amino acids 68–70 of Vpx are critical for HIV-2 infection of
non-dividing cells
Our previous studies demonstrated that mutation of the
basic and tyrosine residues disrupted the ability of GFPVpx to localize to the nucleus of cells (Belshan and Ratner,
2003). Next, we wanted to determine the effects of these
substitutions on the ability of HIV-2 to infect non-dividing
cells. Given the large number of mutants we needed to assay, we developed a short-term arrested-cell assay rather
than utilize the traditional Mf infection assays. Adapted
from the method described by Brussel and Sonigo (2003),
this assay detects integrated viral DNA by nested PCR (see
Materials and methods). For each experiment, U937 cells
were synchronized by serum starvation for 48 h and half of
the cells arrested by release into complete medium containing 400 μM l-mimosine. The other half was released into
complete medium as a dividing cell control. Growth-arrest
of the cells was monitored by propidium iodine staining at
the end of the experiment (data not shown). Genomic DNA

Figure 2. Infection of MAGI-5 cells by viruses containing mutations in Vpx. MAGI-5 cells were infected and virus titer determined as described in Materials and methods. Results are
presented as a comparison to the wild-type ROD10 virus and
represent at least three independent experiments with at least
triplicate infections. Bars denote standard error of the mean.
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was isolated at 0, 24, and 48 h post-infection to assess viral DNA integration by nested PCR. The first PCR uses two
Alu element primers and an HIV-2 LTR-specific primer
with a linker. This PCR amplifies LTR-genome fragments of
various sizes. The second PCR uses the linker primer with
another HIV-2 LTR primer and amplifies a specific product
of 242 bp. The second PCR was performed with [32P]TTP
for visualization of the product by autoradiography after
electrophoresis. Genomic DNA from a known number of
CEMx174 cells chronically infected with HIV-2ST (Kong et
al., 1988) was used as a positive control in each experiment
(data not shown). Each mutant virus was assayed at least
three times and the results presented in Figure 3 represent
the dominant phenotype observed for each viral mutant.
Each individual experiment contained both ROD10 and
the vpx-deleted virus, RMX-Δ. As indicated, ROD10 infected the arrested U937 cells only slightly less well than
the dividing cells (Figure 3). RMX-Δ repeatedly failed to efficiently infect the arrested U937 cells, but still infected the
dividing cells. Therefore, RMX-Δ acted as a negative control in each experiment. Additional controls assayed but
not shown included uninfected cells and cells infected with
heat-inactivated (65 °C for 30 min) ROD10. Integrated virus
was not detected in either of these cells after repeat experiments. Alanine substitution of serine residues 65 and 67
(RMX-S-A) appeared to have no effect on the ability of the
virus to infect non-dividing cells. However, alanine substitution of the three tyrosine residues at positions 66, 69,
and 71 (RMX-Y-A) or both basic residues (K68, R70-RMXKR) abolished infection of the growth-arrested cells. Interestingly, these results correlate well with the cell localization phenotypes we previously observed with mutations in
GFP-Vpx (Belshan and Ratner, 2003).
The conservation and critical requirement of these tyrosine residues for nuclear localization made it tempting to
speculate that phosphorylation of these residues could regulate Vpx function. Although initial studies reported that
HIV-2 Vpx was not phosphorylated (Franchini et al., 1988),
a recent study demonstrated phosphorylation of SIV Vpx
(Rajendra Kumar et al., 2005). However, our own analysis
by [32P]phosphoric acid labeling of either virus or over-expressed Vpx failed to detect any phosphorylation (data not
shown). Furthermore, to assay whether any such modification to the tyrosine residues was important for PIC import,
we constructed a clone in which we substituted phenylalanine at the three tyrosine positions (RMX-Y-F). This virus retained the ability to infect non-dividing cells (Figure
3). These two pieces of evidence suggest that phosphorylation at these tyrosine residues does not regulate HIV2 Vpx function. Further mutation of the tyrosine residues
indicated that Tyr69 alone is critical for the ability of Vpx
to mediate infection of non-dividing cells. This is demonstrated by the fact that any clone containing the Y69A substitution (RMX-66,69A, RMX-69,71A, RMX-69A) was unable to efficiently infect growth-arrested cells. Together, the
results from this series of experiments indicate that amino
acids 68–70 of HIV-2 Vpx are critical for the infection of
non-dividing cells.
We also determined the cell localization phenotype of
GFP-Vpx fusion proteins containing the tyrosine to ala-
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Figure 3. Ability of vpx-NLS mutant viruses to infect arrested and dividing U937 cells. U937 cells were growth arrested and infected as described in Materials and methods. Cells were infected with viruses containing the indicated mutations in vpx. At the
times noted, genomic DNA was harvested and the integration of viral DNA detected by the nested PCR method described in the
Materials and methods. Each mutant was assayed at least three times and the panel presented for each mutant represents the
dominant phenotype. Control PCR assays for the detection of β-globin indicated similar levels of genomic DNA (±10%) were isolated among the samples (data not shown).

nine substitutions. Similar to the pattern of results we previously observed, the fusion proteins containing the three
tyrosine to alanine substitutions (GFP-X-Y-A) or the Y69A
mutation alone (GFP-X-Y69A) displayed a loss of nuclear
accumulation compared to the wild-type GFP-Vpx fusion
protein (GFP-X) (Figure 4). The other constructs containing the Y69A substitution (Y66,69A and Y69,71A) also lost
nuclear accumulation (data not shown). Collectively, these
and our previous localization results (Belshan and Ratner, 2003) demonstrate that amino acids 68–70 are critical

for nuclear localization of Vpx in addition to the ability of
HIV-2 to infect non-dividing cells.
The inability of Vpx NLS mutants to infect non-dividing cells
does not result from a loss of virion associated protein
Vpx is dispensable for replication in dividing, but not
non-dividing cells. To confirm that the defective phenotypes observed in the non-dividing cell infection assay did
not result from an absence of Vpx in the virions and subse-

Figure 4. Alanine substitution of Tyrosine 69 in the Vpx NLS abolishes nuclear accumulation of GFP-Vpx. HeLa cells were transiently transfected with the indicated GFP-Vpx fusion protein constructs. 24 h later, the cells were fixed, permeabilized, stained
with DAPI (lower panels), and imaged with a fluorescence microscope.
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quent PICs, we examined whether the mutant viruses observed to be incompetent to infect non-dividing cells incorporated the mutant Vpx proteins into virions. Virus was
produced by transient transfection of 293T cells. 48 h posttransfection, both the supernatants and cell lysates were
harvested. Virus in the supernatants was concentrated by
ultracentrifugation through a 20% sucrose cushion (w/v in
PBS). Vpx and p27 were detected on separate blots using
monoclonal antibodies (Figure 5). Vpx was detected in all
the mutants except for the vpx-deleted mutant, RMX-Δ, indicating that none of the substitutions were deleterious for
Vpx incorporation into virions. The results were not surprising as previous studies indicate that the determinants
of HIV-2 Vpx packaging map to amino acids 74–86 (Jin et
al., 2001). These results indicate that the failure of the viruses containing the basic or tyrosine mutations to infect
non-dividing cells is not due to an absence of Vpx in the incoming virus particles.
Discussion
HIV-2 Vpx is thought to have arisen as a gene duplication of Vpr, and similar to HIV-1 Vpr Vpx is required for
efficient PIC nuclear import of non-dividing cells (Fletcher
et al., 1996, Sharp et al., 1996, Tristem et al., 1990, and
Tristem et al., 1998). Indeed, Vpx and Vpr sequences comprise a Protein Family (Pfam) domain (PF00522) in their
central regions (aa 5–99) (Bateman et al., 2004), suggesting likely structural and functional conservation among
these proteins. Therefore, it has been proposed that Vpx
uses a method of nuclear import similar to Vpr. Since Vpr
has been shown to interact with importin α (Kamata et al.,
2005, Popov et al., 1998b, and Vodicka et al., 1998) and other

Figure 5. Incorporation of mutant Vpx proteins into virions.
Virus was produced by transient transfection of 293T cells and
virus collected for 48 h. After the final collection, the cell lysates were harvested, then the supernatants precleared and
the virus concentrated by ultracentrifugation through a 20%
sucrose cushion. Proteins were separated by SDS-PAGE and
Vpx and the p27 capsid proteins detected using specific antibodies as indicated.
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nucleoporins (Popov et al., 1998a and Vodicka et al., 1998),
it is likely that Vpr enters the nucleus via the nuclear pore.
Because of their similarities, we initially hypothesized that
Vpx likely utilizes a similar method of nuclear entry as Vpr.
While still a viable hypothesis, several findings suggest that
Vpr may not be a model system for Vpx. We have identified
amino acids 65–72 as a minimal NLS of HIV-2 Vpx, and a
larger domain was confirmed to contain an NLS by Kumar
et al. (Belshan and Ratner, 2003 and Rajendra Kumar et al.,
2003). Further confirmation of the role of this Vpx domain
in nuclear import would involve studies of the effect of mutations described here on HIV-2 replication in macrophages.
However, the parental virus used in this study, ROD-10, replicates inefficiently in macrophages (data not shown). Thus,
transfer of these mutations to a different HIV-2/SIV proviral
clone will be required for these future studies.
There are two points of interest concerning this region of
Vpx. First, this region is not homologous to the Vpr NLS and
lacks any recognizable classical NLS. Second, although this
region is highly conserved among numerous HIV-2/SIV isolates and Vpx and Vpr constitute a Pfam, a predicted structural alignment of Vpx with HIV-1 Vpr the region of Vpx
containing the NLS (aa 65–72) shows weak conservation relative to the highly conserved core domain spanning aa 23–
87. The smaller region is predicted to loop out relative to the
three helix structure in Vpr (Figure 6). Together, this demonstrates the significance of the NLS region of Vpx, but suggests that the function(s) associated with this region is distinct from Vpr. Furthermore, several homology queries of
this region with internet databases yielded no matches.
These data support the possibility that Vpx utilizes a unique
method of nuclear import, dissimilar to that of Vpr. Indeed,
we have performed several yeast two-hybrid screens with
Vpx in attempt to identify the pathway Vpx interacts with
to access the nucleus. In addition, we also assayed Vpx with
a battery of nuclear pore proteins and importins using the
yeast system. While our attempts have yielded no positive
interactions (data not shown), they highlight the differences
between HIV-1 Vpr and Vpx and suggest a novel method of
nuclear transport for Vpx.
Numerous mutations in the Vpx C-terminus have been
identified that disrupt infection of non-dividing cells. A
loss of Vpx function in PIC nuclear targeting may result
from several factors, including, but not limited to either a
block of Vpx incorporation into virions, a disruption of PIC
nuclear import, abolishment of Vpx association with the
PIC, or a loss of interaction with an unknown cellular factor required for PIC import. Interestingly, to date, all of the
mutations in Vpx that disrupt PIC nuclear import or infection of non-dividing cells have been shown to be nuclear
localization defective. This strong correlation suggests that
the critical function of Vpx in PIC nuclear transport is nuclear localization. However, there still remains the question
of the importance of other residues in the C-terminus of
Vpx. Amino acids identified as critical for Vpx nuclear import and HIV-2/SIV infection of non-dividing cells include
residues within and without the characterized NLS, such as
aa 74–80, H82, G86, C87, and the proline-rich region (101–
109) (Belshan and Ratner, 2003, Mahalingam et al., 2001,
and Pancio et al., 2000). Any of these mutations may del-
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eteriously affect Vpx structure, Vpx association with the
PIC, or the interaction of Vpx with a yet-to-be identified
cellular factor. Indeed, none of the Vpx mutants that disrupt PIC nuclear import have been examined for their ability to associate with the PIC. Further structure/function
studies must be undertaken to delineate the role of these
residues in PIC nuclear transport. We observed one result
that directly contrasts another report indicating that triple
tyrosine to alanine mutation in SIV Vpx ablates virion incorporation but has no effect on nuclear localization of Vpx
(Mahalingam et al., 2001). It is presently unclear to us why
we observe a contradictory phenotype, but this may be the
result of disparate methods or differences between HIV-2
and SIV packaging of Vpx. Further studies are required to
delineate the observed differences.
The Vpr/Vpx proteins are considered an important component of the karyophilic signal of the HIV preintegration
complex (PIC). The current data suggest that loss of HIV2/SIV Vpx is more deleterious than the loss of HIV-1 Vpr
(Connor et al., 1995, Haffar et al., 2000, Heinzinger et al., 1994,
Mahalingam et al., 2001, Pancio et al., 2000, Ueno et al., 2003,
and Yu et al., 1991); however, additional and more sensitive
assays with HIV-2/SIV need to be performed to bolster this
conclusion. Similarly, it has been demonstrated in vivo that
deletion of Vpx reduces virus dissemination and productive
infection in pigtailed macaques (Hirsch et al., 1998). Combination of the in vitro and in vivo data supports the idea that
Vpx is a critical karyophilic component of the HIV-2/SIV
PIC. However, it should be noted that neither integrase and
MA NLS mutants, nor cPPT mutants have yet to be assessed
for SIV in vivo. Such studies would likely clarify the in vivo
contribution of each putative karyophilic signal and further
our understanding of PIC nuclear targeting.
Materials and methods
Molecular clone construction and virus production and analysis
ROD10 was a kind gift of Klaus Strebel (Bour et al., 1996).
Mutagenesis of vpx was performed using a shuttling vector
containing a modified SacI–SacI fragment (nt 5284–5876) of
ROD10 in pGEM-T (Promega, Madison, WI). The modification removed the naturally occurring SacI restriction site at
nt 5700. This was accomplished by PCR overlap extension
mutagenesis and did not alter the vpr ORF. The final plasmid (pX-CC) was used to construct the series of mutations
in vpx by overlap extension PCR. Mutagenesis was confirmed by sequencing and then the fragment was digested
and ligated into the parental pROD10. The final clones were
also confirmed by sequencing. The sequences of all primers
were designed from the Genbank sequence of ROD10 (accession # X05291). The sequence of these oligos and those
used for the mutagenesis are available upon request.
Virus stocks were produced by transient transfection of
293T cells. 1 × 106 293T cells were seeded in 10 cm2 plates.
24 h later, the media were changed and the cells were transfected with 20 μg of the plasmid molecular clone using TransIT-LT1 as described by the manufacturer (Mirus Bio, Madison, WI). Every 24 h the media were harvested and replaced
with fresh media. After 72 h, the virus-containing media
were clarified and then concentrated by ultracentrifugation
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Figure 6. Prediction of helical structure in Vpx. Amino acids 23–87 of Vpx were modeled against the HIV-1 Vpr structure (Morellet et al., 2003) using Robetta/Rosetta (Kim et al.,
2004, Chivian et al., 2003, and Rohl et al., 2004). Helix 1–3 indicates predicted a-helices at aa 24–37, 42–59, and 72–86, respectively. The predicted region containing the NLS, aa 60–71, is in
orange between helix 2 and 3. The figure was rendered with
DeepView (Guex and Peitsch, 1997).

(26,000 rpm for 90 min in a Beckman SW28.1 rotor) through
a 20% sucrose cushion. After centrifugation, the media and
sucrose were removed and the pelleted virus resuspended in
OptiMEM (Invitrogen, Carlsbad, CA), aliquoted, and stored
at −80 °C. Virus was quantified by p27 ELISA as described
by the manufacturer (Beckman-Coulter, Miami, FL).
Detection of Vpx in virions
Viruses were produced in the manner described above for
analysis of Vpx incorporation. However, after the 48 h harvest, the virus was clarified and pelleted through 20% sucrose. At this time, the cells were also harvested, washed,
and lysed with 0.5 mL M-PER solution (Pierce Biotechnology, Rockford, IL). Protein concentrations of the cell lysates
were determined by BCA protein assay as described by
the manufacturer (Pierce Biotechnology). The pelleted virus was resuspended directly into 0.25 mL 1× SDS-PAGE
sample buffer. Vpx and p27 capsid were detected by SDSPAGE and Western blotting as follows: Either 20 μL of pelleted virus or 20 μg of cellular protein per lane was separated by SDS-PAGE, then blotted to PVDF. Western blots
for Vpx were performed using a monoclonal anti-Vpx antibody (Kappes et al., 1993) followed by an HRP-conjugated
anti-mouse secondary antibody (Amersham Biosciences,
Piscataway, NJ) and was detected using the ECL Plus system as described by the manufacturer (Amersham Biosciences). The p27 capsid protein was detected using the
AG3.0 anti-p24 monoclonal antibody (Simm et al., 1995)
and an HRP-conjugated anti-mouse secondary antibody.
GFP fusion protein localization
GFP-Vpx is described elsewhere (Pancio et al., 2000).
Mutations were introduced into GFP-Vpx by PCR overlap extension and confirmed by sequencing. HeLa cells
were maintained and transfected similar to 293T cells as
described above. The transfection, fixation, DAPI stain-
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ing, and imaging of cells were performed as previously described (Belshan and Ratner, 2003). Images presented represent the dominant phenotype observed.
Virus infections
The MAGI-5 indicator cell line has been described elsewhere (Pirounaki et al., 2000). The cells were maintained in
DMEM supplemented with 10% fetal calf serum, 4 mM lglutamine, 1 mM Na-pyruvate, and 100 μg/mL penicillin/
streptomycin. To assay virus infection, MAGI-5 cells were
seeded at 0.4 × 104 cells/well in a 96-well plate. The next
day, the cells were infected in triplicate with 1, 5, and 25
ng of virus in the presence of 20 μg/mL of DEAE-dextran.
Forty-eight hours later, the cells were fixed and stained for
the expression of β-galactosidase. The number of blue nuclei was counted to determine the level of infection. Results
are presented as a percentage of the level of infection of the
parental ROD10 and represent a total of at least three independent experiments (therefore 9+ wells for each virus).
U937 cells were maintained in RPMI supplemented
with 15% fetal calf serum, 4 mM l-glutamine, and 100 μg/
mL penicillin/streptomycin. For the experiments examining the infection of arrested cells, 48 h prior to infection, the
cells were pelleted, washed, and resuspended in serumfree RPMI (still containing l-glutamine and antibiotics) to
arrest and synchronize the cells. Immediately prior to infection, the cells were counted and resuspended at 1 × 106
cells/mL in either complete RPMI (dividing) or complete
RPMI containing 4 μM l-mimosine to arrest cells. 4 mL of
cells (4 × 106) was aliquoted into one well of a 6 well plate
for each virus, plus one additional well of dividing and
non-dividing cells for cell-cycle analysis after the infections
were completed. Cells were then infected with 20 μg of virus that had been treated with Turbo DNaseI (Ambion,
Austin, TX) for 30 min at 37 °C. At 0, 24, and 48 h post-infection, 1 mL of cells ( 1 × 106 cells) was removed. Cells
were pelleted, the media removed, and the cells washed,
and resuspended in 0.2 mL PBS. RNA-free, genomic DNA
was isolated using the DNeasy method as described by the
manufacturer, Qiagen (Valencia, CA). After the final time
point, cell-cycle analysis was performed to confirm that the
cells treated with l-mimosine were arrested using the CycleTEST PLUS DNA Reagent kit as described by the manufacturer (Becton Dickinson, San Jose, CA).
Nested Alu PCR
Detection of integrated proviral DNA was performed
using a nested PCR method adapted from Brussel and Sonigo (2003). The initial PCR used 500 nM of HIV-2 LTR
specific primer with a linker (underlined) and two Alu repeat element primers to amplify a pool of products from
the genomic DNA. The HIV-2 primer (LROD13) sequence
was
5′-ATGCCACGTAAGCGAAACTGCGAGGCTGGCAGATTGAGCCCTG-3′. The first Alu primer was 5′TCCCAGCTACTGGGGAGGCTGAGG-3′; the second was
5′-GCCTCCCAAAGTGCTGGGATTACAG-3′. A 20 μL volume PCR reaction was performed using a 1× JumpStart
REDTaq reaction (Sigma, St. Louis, MO) with 4 μL of the
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genomic DNA sample as a template. After an initial 8 min
95 °C incubation to activate the enzyme, 12 cycles of 95
°C for 30 s, 60 °C for 30 s, and 72 °C for 3 min were performed. The second PCR was performed with 2 μL of the
initial PCR using a 1× JumpStart REDTaq reaction supplemented with 0.1 μCi [32P]α-TTP per 20 μL reaction. For
this reaction, 500 nM of the linker primer (5′-ATGCCACGTAAGCGAAACTGC-3′) and an HIV-2 U5-specific primer
(5′-TTACTCAGGTGAACACCGAATGACCAGGC-3′) were
used. After an initial 8 min 95 °C incubation to activate the
enzyme, the reaction conditions for the second PCR were
35 cycles of 95 °C for 30 s, 60 °C for 30 s, and 72 °C for 30 s.
This PCR resulted in the amplification of a 242 bp product.
To visualize the products, 10 μL of each reaction was electrophoresed through an 8% native TBE-polyacrylamide gel.
After electrophoresis, the gel was dried and exposed to autoradiography film. Unfortunately, the nested PCR method
combined with the [32P]TTP labeling resulted in an occasional background band. It was for this reason we analyzed
for integration at both 24 and 48 hpi. Each mutant was also
assayed independently at least three times. The results
present the dominant phenotype observed.
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